Related references
Note: Only part of the references are listed.New Perspectives on the Role of Vitiligo in Immune Responses to Melanoma
Katelyn T. Byrne et al.
Oncotarget (2015)
Over-expression of COX-2 mRNA in colorectal cancer
Hennie M. J. Roelofs et al.
BMC GASTROENTEROLOGY (2014)
Differential effects of 2-and 3-series E-prostaglandins on in vitro expansion of Lgr5+ colonic stem cells
Yang-Yi Fan et al.
CARCINOGENESIS (2014)
Therapeutic potential of the anti- diabetic agent metformin in targeting the skin cancer stem cell diaspora
Anand Reddi et al.
EXPERIMENTAL DERMATOLOGY (2014)
How, and from which cell sources, do nevi really develop?
James M. Grichnik et al.
EXPERIMENTAL DERMATOLOGY (2014)
Trichothecene mycotoxins activate NLRP3 inflammasome through a P2X7 receptor and Src tyrosine kinase dependent pathway
Paivi Kankkunen et al.
HUMAN IMMUNOLOGY (2014)
Caspase-I: The inflammasome and beyond
Gabriel Sollberger et al.
INNATE IMMUNITY (2014)
Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells
Run-Yue Huang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
CANCER Inflammation lights the way to metastasis
Seth B. Coffelt et al.
NATURE (2014)
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
Tobias Bald et al.
NATURE (2014)
Modulation of Mouse Embryonic Stem Cell Proliferation and Neural Differentiation by the P2X7 Receptor
Maynara Fornazari et al.
PLOS ONE (2014)
Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth
M. Mouradian et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2014)
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours
Ashvin Paramanathan et al.
SURGICAL ONCOLOGY-OXFORD (2014)
Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners
H. E. Teulings et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women The Women's Health Initiative
Christina A. Gamba et al.
CANCER (2013)
Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status
Joshua Jabaut et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Dual Role of Apoptosis-Associated Speck-Like Protein Containing a CARD (ASC) in Tumorigenesis of Human Melanoma
Weimin Liu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dynamic Compaction of Human Mesenchymal Stem/Precursor Cells into Spheres Self-Activates Caspase-Dependent IL1 Signaling to Enhance Secretion of Modulators of Inflammation and Immunity (PGE2, TSG6, and STC1)
Thomas J. Bartosh et al.
STEM CELLS (2013)
Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome
Israr Ahmad et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Thromboxane A2 receptor α promotes tumor growth through an autoregulatory feedback pathway
Run-Yue Huang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2013)
TRPM2 links oxidative stress to NLRP3 inflammasome activation
Zhenyu Zhong et al.
NATURE COMMUNICATIONS (2013)
Neuroblastoma-related inflammation May small doses of aspirin be suitable for small cancer patients?
Lena-Maria Carlson et al.
ONCOIMMUNOLOGY (2013)
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Francesco Di Virgilio
PHARMACOLOGICAL REVIEWS (2013)
Melanoma Arising on a Scar 10 Years After a Burn Management and Review of the Literature
Simone Ribero et al.
ANNALS OF PLASTIC SURGERY (2012)
Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma
Clara Curiel-Lewandrowski et al.
CANCER (2012)
Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort
Theodore M. Brasky et al.
CANCER CAUSES & CONTROL (2012)
Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study
J. M. Jeter et al.
CANCER CAUSES & CONTROL (2012)
Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma
Jeffrey H. Dunn et al.
CANCER LETTERS (2012)
Expression of P2X7 Receptor Increases In Vivo Tumor Growth
Elena Adinolfi et al.
CANCER RESEARCH (2012)
A novel role for P2X7 receptor signalling in the survival of mouse embryonic stem cells
Belinda A. N. Thompson et al.
CELLULAR SIGNALLING (2012)
CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
Peter A. Prieto et al.
CLINICAL CANCER RESEARCH (2012)
Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7
Fumie Hattori et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Human skin cancer stem cells: a tale of mice and men
Chantal S. Colmont et al.
EXPERIMENTAL DERMATOLOGY (2012)
Pro-inflammatory cytokine interleukin-1β promotes the development of intestinal stem cells
Lei Wang et al.
INFLAMMATION RESEARCH (2012)
Regulation of neurogenesis and gliogenesis of retinoic acid-induced P19 embryonal carcinoma cells by P2X2 and P2X7 receptors studied by RNA interference
Katia K. Yuahasi et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2012)
Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2
Sonia Alcolea et al.
JOURNAL OF LIPID RESEARCH (2012)
P2X7 Receptor-Pannexin 1 Hemichannel Association: Effect of Extracellular Calcium on Membrane Permeabilization
V. Poornima et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
Yijing Li et al.
MOLECULAR CANCER (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions
Lukasz Kuzbicki et al.
MELANOMA RESEARCH (2012)
Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma
Deepti Verma et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration
Talita Glaser et al.
PURINERGIC SIGNALLING (2012)
ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation
N. Riteau et al.
CELL DEATH & DISEASE (2012)
Cancer-Stimulated Mesenchymal Stem Cells Create a Carcinoma Stem Cell Niche via Prostaglandin E2 Signaling
Hua-Jung Li et al.
CANCER DISCOVERY (2012)
P2X7 Receptor Function in Bone-Related Cancer
Elena Adinolfi et al.
JOURNAL OF OSTEOPOROSIS (2012)
Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion
Lixia Z. Ellis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Cyclooxygenase- and lipoxygenase-mediated DNA damage
N. Speed et al.
CANCER AND METASTASIS REVIEWS (2011)
Inflammasomes: current understanding and open questions
Franz Bauernfeind et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases
Nishkantha Arulkumaran et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
The association between Parkinson's disease and melanoma
Tianhong Pan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Long-Term Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Cutaneous Melanoma: Results of a United States Case-Control Study
Clara Curiel-Lewandrowski et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Constitutive Aberrant Endogenous Interleukin-1 Facilitates Inflammation and Growth in Human Melanoma
Yong Qin et al.
MOLECULAR CANCER RESEARCH (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study
P. Quaglino et al.
ANNALS OF ONCOLOGY (2010)
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
S. J. O'Day et al.
ANNALS OF ONCOLOGY (2010)
Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward
David G. Menter et al.
CLINICAL CANCER RESEARCH (2010)
Interleukins 1α and 1β secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens
Olga Kholmanskikh et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
Miyako Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Jedd D. Wolchok et al.
LANCET ONCOLOGY (2010)
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Konrad Wilhelm et al.
NATURE MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cancer stem cells versus phenotype-switching in melanoma
Keith S. Hoek et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Immunological and Inflammatory Functions of the Interleukin-1 Family
Charles A. Dinarello
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
Wendy K. Nevala et al.
CLINICAL CANCER RESEARCH (2009)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
Jeffrey Weber et al.
CLINICAL CANCER RESEARCH (2009)
Expression of the P2X7 Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis
Elena Adinolfi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Interleukin-1β augments angiogenic responses of murine endothelial progenitor cells in vitro
Anna Rosell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Non-Steroidal Anti-Inflammatory Drugs and Melanoma Risk: Large Dutch Population-Based Case-Control Study
Arjen Joosse et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Multiple melanoma arising on a burn scar and extensive sunburn: a case report and a review of the literature
Matteo Atzeni et al.
MELANOMA RESEARCH (2009)
Marjolin's Ulcer: Modern Analysis of an Ancient Problem
Mahlon A. Kerr-Valentic et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2009)
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
Shankar S. Iyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
Shuiping Tu et al.
CANCER CELL (2008)
Increased P2X(7) receptor expression and function in thyroid papillary cancer: A new potential marker of the disease?
Anna Solini et al.
ENDOCRINOLOGY (2008)
Melanoma, nevogenesis, and stem cell biology
James M. Grichnik
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence
Maryam M. Asgari et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Functional genomics of calcium channels in human melanoma cells
Tamas Deli et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cyclooxygenase-2 (COX-2): first immunohistochernical marker distinguishing early cutaneous melanomas from benign melanocytic skin turnours
Barbara W. Chwirot et al.
MELANOMA RESEARCH (2007)
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence
Eric J. Jacobs et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
NALP1 in vitiligo-associated multiple autoimmune disease
Ying Jin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Interleukin-1β-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors
Yakov Krelin et al.
CANCER RESEARCH (2007)
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic
D. J. A. de Groot et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor
Pablo Pelegrin et al.
EMBO JOURNAL (2006)
Celecoxib for the prevention of colorectal adenomatous polyps
Nadir Arber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Squamous cell carcinoma developing on burn scar
Ü Gül et al.
ANNALS OF PLASTIC SURGERY (2006)
The P2X7 receptor:: A key player in IL-1 processing and release
Davide Ferrari et al.
JOURNAL OF IMMUNOLOGY (2006)
Microsomal prostaglandin E2 synthase-I in breast cancer:: a potential target for therapy
S Mehrotra et al.
JOURNAL OF PATHOLOGY (2006)
Melanoma, a tumor based on a mutant stem cell?
James M. Grichnik et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Human melanomas express functional P2X7 receptors
N White et al.
CELL AND TISSUE RESEARCH (2005)
Cyclooxygenase-2-mediated DNA damage
SH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial
NR Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Use of cyclooxygenase inhibitors and risk of melanoma in high-risk patients
CC Ramirez et al.
DERMATOLOGIC SURGERY (2005)
Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth
E Adinolfi et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release
JM Kahlenberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Mechanism for IL-1β-mediated neovascularization unmasked by IL-1β knock-out mice
K Amano et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma
C Miki et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Three cases of malignant melanoma arising on burn scars
H Kikuchi et al.
JOURNAL OF DERMATOLOGY (2003)
Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells
AVH Greig et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Essential role for Ca2+ in regulation of IL-1β secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells
L Gudipaty et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Inhibition of IL-1β-dependent prostaglandin E2 release by antisense microsomal prostaglandin E synthase 1 oligonucleotides in A549 cells
FJ Sweeney et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Increased expression of apoptotic markers in melanoma
M Slater et al.
MELANOMA RESEARCH (2003)
IL-1 is required for tumor invasiveness and angiogenesis
E Voronov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Serum caspase-1 levels in metastatic melanoma patients: relationship with tumour burden and non-response to biochemotherapy
R Mouawad et al.
MELANOMA RESEARCH (2002)
De novo tumors after liver transplantation: A single-institution experience
EQ Sanchez et al.
LIVER TRANSPLANTATION (2002)
Enhanced IL-18 expression in common skin tumors
H Park et al.
IMMUNOLOGY LETTERS (2001)
Malignant melanoma arising within a burn scar - Case report and review of the literature
PM Spring et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
